We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

7 hedge funds and large institutions have $506K invested in ENDRA Life Sciences in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.63% less ownership

Funds ownership: 5.62% → 4.98% (-0.63%)

30% less funds holding

Funds holding: 10 → 7 (-3)

53% less capital invested

Capital invested by funds: $1.08M → $506K (-$579K)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$25.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.38K
3
UBS Group
UBS Group
Switzerland
+$8.38K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$8.38K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$86K
2
State Street
State Street
Massachusetts
-$32K
3
Citadel Advisors
Citadel Advisors
Florida
-$23K
4
Northern Trust
Northern Trust
Illinois
-$19K
5
TRCT
Tower Research Capital (TRC)
New York
-$8.38K

NDRA Hedge Fund Activity: Q4 2022 in Review

7 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2022, worth a combined $506K — down 53% from $1.08M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NDRA and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $25.1K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $86K sold.

  • 7 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2022, down from 10 in Q3 2022.
  • Funds reported $506K of ENDRA Life Sciences stock for Q4 2022, down 53% quarter-over-quarter.
  • 2 funds opened new ENDRA Life Sciences positions in Q4 2022 and 5 closed out, a net change of -3 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2022 was JP Morgan Chase, an estimated $25.1K added.
  • The largest ENDRA Life Sciences seller in Q4 2022 was Renaissance Technologies, an estimated $86K sold.

Based on aggregated 13F filings for Q4 2022.